Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 108 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $421,225 | -62.9% | 77,289 | -53.7% | 0.00% | – |
| Q2 2023 | $1,133,855 | +45.4% | 166,989 | +7.3% | 0.00% | – |
| Q1 2023 | $779,751 | +2.7% | 155,639 | 0.0% | 0.00% | – |
| Q4 2022 | $759,518 | -97.6% | 155,639 | -92.8% | 0.00% | -100.0% |
| Q3 2022 | $31,004,000 | -27.2% | 2,150,064 | -23.6% | 0.02% | -21.1% |
| Q2 2022 | $42,604,000 | +20.8% | 2,815,865 | -5.2% | 0.02% | +35.7% |
| Q1 2022 | $35,274,000 | +12.0% | 2,969,159 | +52.9% | 0.01% | +27.3% |
| Q4 2021 | $31,485,000 | -22.2% | 1,942,334 | +37.0% | 0.01% | -31.2% |
| Q3 2021 | $40,464,000 | -11.2% | 1,417,809 | +5.1% | 0.02% | -11.1% |
| Q2 2021 | $45,583,000 | +22.4% | 1,348,596 | +9.5% | 0.02% | +12.5% |
| Q1 2021 | $37,236,000 | -25.6% | 1,231,338 | +21.9% | 0.02% | -33.3% |
| Q4 2020 | $50,021,000 | +35.8% | 1,010,319 | +5.3% | 0.02% | +20.0% |
| Q3 2020 | $36,836,000 | -3.9% | 959,516 | +8.1% | 0.02% | -13.0% |
| Q2 2020 | $38,336,000 | +56.6% | 887,397 | -5.4% | 0.02% | +27.8% |
| Q1 2020 | $24,475,000 | -7.3% | 937,729 | +11.0% | 0.02% | +20.0% |
| Q4 2019 | $26,390,000 | +32.3% | 844,464 | +10.3% | 0.02% | +25.0% |
| Q3 2019 | $19,954,000 | +17.2% | 765,701 | +2.9% | 0.01% | +9.1% |
| Q2 2019 | $17,019,000 | -2.2% | 744,155 | +12.1% | 0.01% | 0.0% |
| Q1 2019 | $17,404,000 | +53.8% | 664,006 | +19.4% | 0.01% | +37.5% |
| Q4 2018 | $11,316,000 | +31.1% | 556,338 | +71.2% | 0.01% | +33.3% |
| Q3 2018 | $8,632,000 | – | 324,990 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
| Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
| MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
| Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
| Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
| Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
| Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
| ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
| Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
| Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |